![](/img/cover-not-exists.png)
The Oral Histone Deacetylase Inhibitor LBH589 Is a Potential and Promising Therapeutic Agent in Multiple Myeloma after at Least Two Lines of Chemotherapy Including Bortezomib or Lenalidomide
Schmitt, Stefan, Ho, Anthony D., Goldschmidt, HartmutVolume:
33
Year:
2010
Journal:
Onkologie
DOI:
10.1159/000286447
File:
PDF, 597 KB
2010